| 
			
			 The case of Bertila Boyd-Bostic, who died of a rare form of cancer 
			in 2017 at the age of 30, is the latest in a series of trials in the 
			United States that center around allegations that the company's 
			talc-based powder contains cancer-causing asbestos. 
 In May, a deadlocked jury at the Darlington County Court of Common 
			Pleas in Charleston failed to reach a verdict in the first trial.
 
 J&J, which denies the allegations, to date has lost two trials and 
			won three in the litigation over whether Johnson's Baby Powder 
			causes mesothelioma, a tissue cancer closely linked to asbestos 
			exposure. Jury trials in another four mesothelioma cases have 
			resulted in mistrials because jurors could not agree on a verdict or 
			because the plaintiff died.
 
			
			 
			
 J&J, faced with some 11,700 U.S. talc lawsuits, in a statement on 
			Thursday said it believed the mistrials, as well as the verdicts 
			clearing it of liability reflected the "diligent review" by juries 
			in the cases.
 
 "We look forward to a new trial to present our defense, which rests 
			on decades of independent, non-litigation-driven scientific 
			evaluations, none of which have found that Johnson's Baby Powder 
			contains asbestos," the company said.
 
 Christopher Swett, a lawyer for Boyd-Bostic's family, in a statement 
			said plaintiffs were disappointed with Thursday's result. Swett said 
			the trial court judge had urged the parties to consider a 
			settlement, but that J&J "refuses to be reasonable and take 
			responsibility."
 
 
 [to top of second column]
 | 
 
			The New Brunswick, New Jersey-based company in the past has said 
			that it was not considering to settle talc cases and currently is 
			appealing all jury verdicts against it.
 Of the 11,700 talc lawsuits, more than 9,700 involve claims over 
			ovarian cancer, recent filings in federal court in New Jersey, where 
			most of the cases are consolidated, showed.
 
 The remaining plaintiffs allege asbestos in J&J's talc caused them 
			to develop mesothelioma.
 
 J&J has been fighting talc cancer lawsuits for several years, but 
			the litigation shifted in recent months to include allegations of 
			asbestos contamination.
 
 In July, a Missouri jury hit J&J with a massive $4.69 billion 
			verdict in the first trial alleging asbestos contamination has 
			caused ovarian cancer in 22 women. That decision is under appeal.
 
 (Reporting by Tina Bellon; Editing by Leslie Adler)
 
			[© 2018 Thomson Reuters. All rights 
				reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. 
			
			
			 |